Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 162

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 16G
Chunk 162
---
Item 16g. Corporate
Governance

Under Nasdaq Stock Market
Rule 5615(a)(3), foreign private issuers, such as our company, are permitted to follow certain home country corporate governance practices
instead of certain provisions of the Nasdaq Stock Market Rules. A foreign private issuer that elects to follow a home country practice
instead of any such Nasdaq rules must submit to Nasdaq, in advance, a written statement from an independent counsel in such issuer’s
home country certifying that the issuer’s practices are not prohibited by the home country’s laws. We submitted such a written
statement to Nasdaq. See “ Item 6. Directors, Senior Management and Employees - C. Board Practices - Corporate Governance
Requirements under Nasdaq listing rules” for a summary of such differences.

Item 16h. Mine Safety
Disclosure